期刊文献+

罗氟司特对脂多糖诱导的急性肺损伤大鼠的保护作用 被引量:2

Roflumilast alleviates lipopolysaccharide-induced acute lung injury in rats
原文传递
导出
摘要 目的探讨磷酸二酯酶4抑制剂罗氟司特对脂多糖(LPS)诱导的急性肺损伤大鼠的保护作用。方法 30只健康雌性SD大鼠随机分为三组,每组10只。模型组和治疗组给予LPS 8 mg·kg^(-1)造模,对照组给予生理盐水。注入LPS前2 h,治疗组予罗氟司特5 mg·kg^(-1)灌胃。检测三组大鼠支气管肺泡灌洗液(BALF)中的细胞总数和中性粒细胞数,肺组织湿干重比及病理学评分。RT-PCR和Western blot测定肺组织上皮钠通道α(α-ENaC)的表达水平。结果与对照组相比,模型组BALF中细胞总数和中性粒细胞数、肺组织湿干重比和病理学评分增高(P<0.05或P<0.01),α-ENaC的蛋白和mRNA表达下降(P<0.05)。治疗组BALF中细胞总数和中性粒细胞数、肺组织湿干重比和病理学评分低于模型组,α-ENaC的蛋白和mRNA表达水平高于模型组,差异均有显著意义(P<0.05)。结论罗氟司特可通过促进肺组织α-ENaC的表达,减轻急性肺损伤大鼠的肺水肿,并可抑制炎症反应,对急性肺损伤大鼠有一定的保护作用。 AIM To investigate the effects of roflumllast on llpopmysaccnarlue (LPS)-induced acutelung injury (ALI) in rats. METHODS Thirty SD rats were randomly divided into 3 groups (n =10), including control group, model group and trim group. In the model group and trial group, LPS was injected through left jugular veins with 8 mg .kg^-1 to build ALI model. Two hours before LPS injected, roflumilast was administrated intragastrically at 5 mg.kg^-1 in the trial group. Then the numbers of total cells and neutrophils in bronchoalveolar lavage fluid (BALF) were counted. Wet to dry ratio (W/D) of lung was analyzed. HE staining was used to observe lung injury score. RT-PCR and Western blot were included to measure the expression of α- epithelial sodium channel (α-ENaC). RESULTS The numbers of total cells and neutrophils in BALF, W/Dand lung injury score were increased in the model group compared with the control group (P 〈 0.05 or P 〈 0.01). And the expressions of eL-ENaC were reduced at both mRNA and protein levels in the model group (P 〈 0.05). Compared with the model group, the numbers of total cells and neutrophils in BALF, W/D and lung injury score were reduced in the trial group and the expressions of cx- ENaC were up- regulated (P 〈 0.05) . CONCLUSION Roflumilast can alleviate LPS- induced lung edema via up- regulation α- ENaC and reducing inflammation response, indicating a protective effect of roflumilast in LPS induced ALI model in rats.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2013年第10期815-818,共4页 Chinese Journal of New Drugs and Clinical Remedies
基金 四川省教育厅课题(11ZB172) 成都医学院课题资助项目(CYZ11-015)
关键词 罗氟司特 磷酸二酯酶抑制剂 肺水肿 上皮钠通道 roflumilast phosphodiesterase inhibitors lung edema epithelial sodium channel
  • 相关文献

参考文献11

  • 1SARTOHI C, MATTHAY MA, Alveolar epithelial fluid transportin acute lung injury: new insights[J]. Eur Hespir, 2002, 20(5):1299-1313.
  • 2ELIAS N, RAFII B, BRHMAN M, et al. The role of alpha -,beta -,and gamma - ENaC subunits in distal lung epithelial fluidabsorption induced by pulmonary edema fluid [J]. Am J PhysiolLung Oil Mol Physiol, 2007, 293(3): L537-IJ45.
  • 3MUSTAFA SB, CASTRO H, FALCK AJ, et al. Protein kinase Aand mitogen - activated protein kinase pathways mediate ( AMPinduction of alpha-epithelial Na+ channels (alpha-ENaC )[J]. JCell Physiol, 2008, 215 (1): 101-110.
  • 4ZAMBON AC, WILDEKMAN A, HO A, et al. Increasedexpression of the pro - apoplotic protein BIM : a mechanism foroAMP/protein kinase A (PKA) - induced apoptosis of immature Tcells[J]. J Biol Chem, 2011,286(38): 33260-33267.
  • 5MARTORANA PA, BEUMK R, LUCATTKIXI M, et al.Roflumilast fully prevents emphysema in mice chronicallyexposed to cigarette smoke[J]. Am J Respir Crit Care Med, 2005,172(7): 848-853.
  • 6JANSSON AH, ERIKSSON C,WANG XD. Effects of budesonideand N-acetylcysteine on acute lung hyperinflation, inflammationand injury in rats[J]. Vasoul Pharmacol, 2005 , 43(2): 101-111.
  • 7OTULAKOWSKI G, HAFII B, HARRIS U, et al. Oxygen andglucocorticoids modulate alphaENaC mRNA translation in fetaldistal lung epithelium[J]. Am J Respir Cell Moll Biol, 2006, 34(2): 204-212.
  • 8U T, KOSHY S, FOLKESSON HG. RNA interference for CFTRattenuates lung fluid absorption at birth in ratw[J]. Respir Res,2008,9: 55.
  • 9MORRIS RG, SCHAFER JA. cAMP increases density of ENaCsubunits in the apical membrane of MDCK cells in directproportion to amiloride - sensitive Na* transport[J]. J Gen Physiol,2002, 120(1): 71-85.
  • 10THOMAS CP, CAMPBELL JH, WRIGHT PJ, et al. cAMP-stimulated Na* transport in H441 distal lung epithelial cells: roleof PKA, phosphatidylinositol 3-kinase, and sgkl[J]. Am J PhysiolLung Cell Mol Physiol, 2004, 287(4): L843-I^51.

二级参考文献26

  • 1GOLD executive committee. Global strategy for the diagnosis,management, and prevention of chronic obstructive pulmonary disease [EB/OL]. /2010-12) [2011-0g-18]. http ://www.gold- copd.org.
  • 2HOGG JC. Pathophysiology of airway limitation in chronic ob- structive pulmonary disease[J]. Lancet, 2004, 364(9435): 709- 721.
  • 3ESSAYAN DM. Cyclic nucleotide phosphodiesterases [J]. J Al- lergy Clin Immunol, 2001, 108(5): 671-680.
  • 4SODERLING SH, BEAVO JA. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions[J]. Curr Opin Cell Biol, 2000, 12(2): 174-179.
  • 5HUM Q, WANG H, SUN Y, et ol. Three-dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity[J]. Structure, 2003, 11(7):865-873.
  • 6FUJISHIGE K, KOTERA J, MICHIBATA H, et ol. Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A)[J]. J Biol Chem, 1999, 274(26) : 18438-18445.
  • 7SPINA D. PDE4 inhibitors: current status[J]. Br J Pharmacol, 2008,155(3) : 308-315.
  • 8SOUNESS JE, RAO S. Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases[J]. Cell Sig- nal, 1997, 9(3-4): 227-236.
  • 9EHRMAN TM, BARLOW DJ, HYLANDS PJ. In silico search for multi-target anti-inflammatories in Chinese herbs and for- mulas[J]. Bioorg Med Chem, 2010, 18(6) : 2204-2218.
  • 10MARTORANA PA, BEUMA R, LUCATTELLI M, et al. Roflu- milast fully prevents emphysema in mice chronically exposed to cigarette smoke[J]. Am J Respir Crit Care Med, 2005, 172(7): 848-853.

共引文献7

同被引文献12

  • 1王瑞倩,卞涛.选择性磷酸二酯酶抑制剂罗氟司特在慢性阻塞性肺疾病抗炎作用的研究进展[J].中华哮喘杂志(电子版),2012,6(6):441-446. 被引量:10
  • 2BETHKE TD, BOHMER GM, HERMANN R, et al. Dose- proportional intraindividual single- and repeated- dose pharma- cokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor[J]. J Clin Pharmaeol, 2007, 47 ( 1 ) : 26-36.
  • 3KNEBEL NG, HERZOG R, REUTTER F, et d. Sensitive quantification of rotlumilast and rotlumilast N-oxide in human plasma by LC- MS/MS employing parallel chromatography and eleetrospray ionisation[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2012, 893-894: 82-91.
  • 4THAPPALI SR, VARANASI KV, VEERARAGHAVAN S, et ~d. Simultaneous quantitation of IC87114,rflumilast and its active metabolite roflumilast N- oxide in plasma by LC-MS/MS: application for a pharmaeokinetic study [J]. J Mass Speetrom, 2012, 47(12): 1612-1619.
  • 5NEVILLE KA, SZEFLER S J, ABDEI,-RAHMAN SM, et al. Single- dose pharmaeokineties of roflumilast in children and adolescents[J]. J Clin Pharmaeol, 2008, 48(8): 978-985.
  • 6NASSR N, LAHU G, yon RICHTER O, et d. Lack of a pharmaeokinetie interaction between steady-state roflumilast and single-dose midazolam in healthy subjects[J]. Br J Clin Pharmaeol, 2006, 63(3) : 365-370.
  • 7de MEY C, NASSR N, LAHU G. No relevant cardiac, pharmaeokinetie or safety interactions between roflumilast and inhaled formoterol in healthy subjects: an open- label, randomised, aetively controlled study[J]. BMC Clin Pharmaeol, 2011. ll: 7.
  • 8李燕舞.无创通气治疗重度支气管哮喘急性发作50例临床分析[J].中国全科医学,2010,13(7):787-789. 被引量:25
  • 9祝巍,陈萍.磷酸二酯酶抑制药——罗氟司特在慢性阻塞性肺疾病治疗中的应用[J].中国新药与临床杂志,2011,30(11):819-823. 被引量:8
  • 10徐朝江,王卓.罗氟司特的药动学和安全性研究进展[J].医药导报,2013,32(3):321-325. 被引量:6

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部